Clinical Trials Logo
  1. Home
  2. Nephropathy
  3. NCT06456801
  4. Details
NCT06456801 Clinical Trial

Clinical Trial of Anti-PLA2R-IgG Detection Kit (Time-resolved Fluorescence Immunoassay)

Nephropathy Clinical Trial

Official title:
Clinical Trial of Anti-PLA2R-IgG Detection Kit (Time-resolved Fluorescence Immunoassay)

Clinical Trial Details — Status: Completed

Administrative data
NCT number NCT06456801
Other study ID # zjbs-pla2r-2012
Secondary ID
Status Completed
Phase
First received
Last updated
Start date March 1, 2021
Est. completion date October 1, 2021

Study information
Verified date June 2024
Source Zhejiang University
Contact n/a
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

Conduct comparative experimental studies on clinical serum samples using assessment reagents and approved products, and evaluate the equivalence between assessment reagents and comparison reagents.

Description:

Conduct comparative experimental studies on clinical serum samples using assessment reagents and approved products, and evaluate the equivalence between assessment reagents and comparison reagents.

Recruitment information / eligibility
Status Completed
Enrollment 219
Est. completion date October 1, 2021
Est. primary completion date October 1, 2021
Accepts healthy volunteers No
Gender All
Age group N/A and older
Eligibility Inclusion Criteria: Clear background information and traceable sources of samples from kidney disease patients (number, age, gender, and clinical diagnostic information). Exclusion Criteria: Exclude serum samples that meet one of the following conditions: ? Samples with insufficient sample size, ? Samples with incomplete sample information.

Study Design

Related Conditions & MeSH terms

Locations
Country Name City State
China The First Affiliated hospital Zhejiang University school of medicine Hangzhou Zhejiang

Sponsors (1)
Lead Sponsor Collaborator
Zhejiang University

Country where clinical trial is conducted

China, 

Outcome
Type Measure Description Time frame Safety issue
Primary Calculate the correlation between the test reagents and comparison reagents Calculate the correlation between the test reagents and comparison reagents 1 year.
See also
  Status Clinical Trial Phase
Enrolling by invitation NCT05530356 - Renal Hemodynamics, Energetics and Insulin Resistance: A Follow-up Study
Recruiting NCT01448889 - Normobaric Hyperoxygenation for Prevention of Contrast Induced Nephropathy N/A
Active, not recruiting NCT05026021 - Prediction of BKvirus Nephropathy Risk by the NEPHROVIR Method in Kidney Transplant Patients With BKvirus Viremia
Completed NCT02470247 - Interest of Remote Ischemic Preconditioning for Prevention of Contrast Medium-induced Nephropathy in High Risk Patients N/A
Recruiting NCT05511779 - Study to Confirm of the Safety and Tolerability of Brincidofovir in Subjects With BK Virus Infection (Viremia) After Kidney Transplantation Phase 2
Active, not recruiting NCT03620773 - Impact of Metabolic Surgery on Pancreatic, Renal and Cardiovascular Health in Youth With Type 2 Diabetes Phase 1/Phase 2
Active, not recruiting NCT03584217 - Renal HEIR Study: Renal Hemodynamics, Energetics and Insulin Resistance in Youth Onset Type 2 Diabetes Study Phase 1/Phase 2
Completed NCT03618420 - Copeptin in Adolescent Participants With Type 1 Diabetes and Early Renal Hemodynamic Function Phase 1/Phase 2
Completed NCT02575092 - The Relationship Between HHcy and Contrast-induced Nephropathy in Hypertensive Patients After Coronary Artery Diagnosis and Treatment Phase 2/Phase 3
Recruiting NCT05839314 - Effect of Huaier Granule on the Treatment of Idiopathic Membranous Nephropathy Phase 4
Completed NCT01638663 - Effect of the Aquaretic Tolvaptan on Nitric Oxide System (TORA) Phase 2
Completed NCT01214746 - The Effects of Atorvastatin on the Nitric Oxide-system in Healthy Young Man Phase 2
Completed NCT01208701 - The Effects of Atorvastatin on the Nitrogen Oxide-system in Patients With Type 2 Diabetes and Nephropathy Phase 2
Completed NCT01213498 - The Effects of Atorvastatin on the Nitric Oxide-system in Patients With Non-diabetic Nephropathy Phase 2
Active, not recruiting NCT00655330 - Probucol Combined With Valsartan in Reducing Proteinuria in Diabetes Nephropathy N/A
Completed NCT00308347 - A Research Study to Evaluate the Renal (Kidney) Protective Effects of Losartan in Patients With Non-insulin Dependent Diabetes (0954-147)(COMPLETED) Phase 3
Terminated NCT00579995 - A Prospective, Randomized TrialComparing Oral N-Acetylcysteine and Intravenous Sodium Bicarbonate N/A
Completed NCT05986474 - Development of Synthetic Medical Data Generation Technology to Predict Postoperative Complications
Recruiting NCT03886714 - Screening for Fabry Disease in Renal Transplantation
Recruiting NCT06325059 - The Role of Renal Progenitors and Polyploid Tubular Cell Response in Glomerular and Tubular Diseases N/A